Upashita Intravenous Injection for Dialysis 50μg Syringe contains upacicalcet sodium hydrate and is manufactured by Sanwa Chemical Research Institute. Upashita is used to treat secondary hyperparathyroidism in patients undergoing hemodialysis. This injectable drug, with YJ code 3999460G2028, is supplied as 50μg in 1mL per tube.
Upashita Intravenous Injection for Dialysis 50μg Syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).